SNAI1, an endothelial–mesenchymal transition transcription factor, promotes the early phase of ocular neovascularization

• Published in: Angiogenesis (London) Vol. 21; no. 3; pp. 635 - 652
• Main Authors: Sun, Jia-Xing, Chang, Tian-Fang, Li, Man-Hong, Sun, Li-Juan, Yan, Xian-Chun, Yang, Zi-Yan, Liu, Yuan, Xu, Wen-Qin, Lv, Yang, Su, Jing-Bo, Liang, Liang, Han, Hua, Dou, Guo-Rui, Wang, Yu-Sheng
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.08.2018; Springer Nature B.V
• Subjects: Age; Angiogenesis; Biomedical and Life Sciences; Biomedicine; Cancer Research; Cardiology; Cell Biology; Cell migration; Cytoskeleton; Endothelial cells; Extracellular matrix; Gene expression; Macular degeneration; Mesenchyme; Nucleotide sequence; Oncology; Ophthalmology; Original Paper; Phenotypes; Physiological effects; Retina; Retinopathy; Ribonucleic acid; RNA; siRNA; Snail protein; Therapeutic applications; Transcription factors; Vascular endothelial growth factor; Vascularization; Endothelial–mesenchymal transition; SNAI1; Angiogenesis; Choroidal neovascularization; Oxygen-induced retinopathy
• ISSN: 0969-6970; 1573-7209
• DOI: 10.1007/s10456-018-9614-9

Ocular neovascularization is a comprehensive process involved in retinal vascular development and several blinding diseases such as age-related macular degeneration and retinopathy of prematurity, with vascular endothelial growth factor (VEGF) regarded as the master regulator. However, the qualified effect of anti-VEGF therapy reveals that the underlying mechanisms are still not clearly identified. To initialize angiogenesis, endothelial cells undergo a phenotype switching to generate highly migratory and invasive cells. This process shares certain similar characters observed in endothelial–mesenchymal transition (EndMT). Here, we found that SNAI1, an EndMT transcription factor, was expressed by endothelial cells in both physiological and pathological ocular neovascularization. SNAI1 overexpression triggered cell morphological change and enhanced cell motility, while loss of SNAI1 attenuated migration, invasion and sprouting. RNA sequence analysis further revealed that SNAI1 knockdown decreased the expression of genes related to cytoskeleton rearrangement and ECM remodeling. Moreover, intravitreal injection of small interfering RNA of SNAI1 suppressed new vessel formation in developing retina as well as mice model of choroidal neovascularization and oxygen-induced retinopathy. Therefore, we propose that the EndMT transcription factor SNAI1 promotes the early phase of ocular neovascularization and may provide a potential therapeutic target.